Announcements Trials

Browse Landscape

Phase

Phase 2 16 Phase 1/2 8 Phase 1 8 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 95 Carcinoma, Non-Small-Cell Lung 87 Lung Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 19 Melanoma 19 Triple Negative Breast Neoplasms 14 Stomach Neoplasms 13 Breast Neoplasms 13 Neoplasm Metastasis 11 Head and Neck Neoplasms 11 Carcinoma, Renal Cell 11 Endometrial Neoplasms 10 Urinary Bladder Neoplasms 9 Neoplasms 9 Carcinoma 9 Carcinoma, Transitional Cell 7 Carcinoma, Hepatocellular 7 Colorectal Neoplasms 6 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Neoplasms by Site 4 Esophageal Neoplasms 4 Cholangiocarcinoma 4 Thoracic Neoplasms 3 Small Cell Lung Carcinoma 3 Skin Neoplasms 3 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Lung Diseases 3

Interventions

Radiosurgery 23 Radiotherapy 20 Temozolomide 17 Lomustine 9 Bevacizumab 8 Surgical Procedures, Operative 7 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Specimen Handling 3 Sodium Chloride 3 Radiation 3 Methylphenidate 3 Mental Status and Dementia Tests 3 Granulocyte Colony-Stimulating Factor 3 Gefitinib 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 Carmustine 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × pembrolizumab × Clear all

NCT05317858 2026-04-16

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡